Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Xtant Medical Holdings (XTNT) Return on Sales (2016 - 2025)

Xtant Medical Holdings (XTNT) has disclosed Return on Sales for 16 consecutive years, with 0.04% as the latest value for Q3 2025.

  • On a quarterly basis, Return on Sales rose 22.0% to 0.04% in Q3 2025 year-over-year; TTM through Sep 2025 was 0.01%, a 17.0% increase, with the full-year FY2024 number at 0.14%, down 15.0% from a year prior.
  • Return on Sales was 0.04% for Q3 2025 at Xtant Medical Holdings, down from 0.1% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.37% in Q3 2023 to a low of 0.18% in Q3 2024.
  • A 5-year average of 0.07% and a median of 0.12% in 2023 define the central range for Return on Sales.
  • Peak YoY movement for Return on Sales: soared 53bps in 2023, then plummeted -55bps in 2024.
  • Xtant Medical Holdings' Return on Sales stood at 0.17% in 2021, then increased by 15bps to 0.14% in 2022, then decreased by -6bps to 0.15% in 2023, then skyrocketed by 35bps to 0.1% in 2024, then surged by 139bps to 0.04% in 2025.
  • Per Business Quant, the three most recent readings for XTNT's Return on Sales are 0.04% (Q3 2025), 0.1% (Q2 2025), and 0.0% (Q1 2025).